PharmaShots | Incisive News in 3 Shots

Subscribe Now

Front-Line

Debiopharm's Debio 1143 Receives the US FDA's Breakthrough Therapy Designation for Front-Line Treatment of Head and Neck Cancer

Debiopharm's Debio 1143 Receives the US FDA's Breakthrough Therapy Designation for Front-Line Treatment of Head and Neck Cancer

February 27, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us